A daily pill, Xarelto works by blocking a clotting protein. Older blood thinners, including warfarin, work by preventing platelets from sticking together.

Giving the anti-clotting drug rivaroxaban to patients for 12 weeks instead of the usual six after a blood clot in the lower leg reduces the risk of further clots developing up to two years after ...

FDA approves two new indications for Xarelto ® (rivaroxaban) to help prevent and treat blood clots in pediatric patients. News release. Janssen Pharmaceutical Companies of Johnson & Johnson.

Participants were randomized and administered monthly injections of 150 mg abelacimab, 90 mg abelacimab, or standard dosing of rivaroxaban (20 mg or 15 mg in dose reduced patients).

The anti-clotting drug rivaroxaban helps lower the risk of heart attack, stroke and death in patients who are hospitalized for a heart attack or chest pain, according to a study released Sunday.

June 18 -- WEDNESDAY, June 17 (HealthDay News) -- The new anti-clotting pill rivaroxaban (Xarelto) lowers the risk of stroke, heart attack and death in patients who have had a heart attack or ...

Learn about side effects, dosage, and more for Xarelto (rivaroxaban), which is a prescription drug that prevents and treats blood clots in certain people.

This review reports on the trial data now supporting the clinical use of rivaroxaban and discusses the potential role of this agent in daily clinical practice.

Giving the anti-clotting drug rivaroxaban to patients for 12 weeks instead of the usual six after a blood clot in the lower leg reduces the risk of further clots developing up to two years after ...

Find all the latest on rivaroxaban at Medical Xpress. Your go-to source for news, research, and medical breakthroughs.

Cite this: Rivaroxaban for the Prevention of Venous Thromboembolism Following Major Orthopedic Surgery: The RECORD Trials - Medscape - Jun 01, 2009.